Successful treatment of retinopathy of prematurity in oculocutaneous albinism with OCA2 variants: a case report and review of literature

Xiao-Yu Zheng,Ding-Wen Wu,Lan Yu,Zheng-Yan Zhao

DOI: https://doi.org/10.1186/s12887-024-04864-2

2024-06-11

BMC Pediatrics

Abstract:Oculocutaneous albinism (OCA) is a group of autosomal recessive hereditary disorders that affect melanin biosynthesis, resulting in abnormalities in hair, skin, and eyes. Retinopathy of prematurity (ROP) is a proliferative retinopathy mainly observed in premature infants with low birth weight and early gestational age, but it can also affect full-term infants or children with normal weight, particularly in developing countries. The coexistence of ROP and OCA is rare. There is limited documentation regarding treatment approaches, with few studies reporting positive outcomes with laser treatment due to the absence of melanin pigment. This study discusses the treatment challenges in a female infant diagnosed with ROP and OCA, and underscores the importance of genetic analysis in guiding therapeutic decisions for this rare comorbid condition.

pediatrics

What problem does this paper attempt to address?

This paper reports a case of a premature female infant with both retinopathy of prematurity (ROP) and oculocutaneous albinism (OCA), and discusses the treatment challenges and successful methods when these two rare conditions coexist.

### Research Background

- **OCA**: An autosomal recessive genetic disorder that affects melanin synthesis, leading to abnormalities in hair, skin, and eyes.
- **ROP**: A proliferative retinopathy primarily occurring in low birth weight or premature infants, but can also affect full-term infants in developing countries.
- **Coexistence of OCA and ROP**: This condition is extremely rare, and there are limited reports in the literature on the treatment of ROP in this comorbid state.

### Case Presentation

- The patient is a female infant born at 31 weeks of gestation, with a birth weight of 1560 grams, diagnosed with ROP and OCA.
- Genetic testing revealed that the patient carries two variants of the OCA2 gene (c.727C>T[p.R243C] and c.1832T>C[p.L611P]), inherited from the mother and father respectively, confirming OCA type 2.
- Initial treatment with anti-vascular endothelial growth factor (anti-VEGF) injections was administered, but ROP recurred.
- Ultimately, laser photocoagulation therapy successfully controlled the condition, with no recurrence of ROP observed during a 2-month follow-up period.

### Conclusion

- This is the first reported case of coexistence of ROP and OCA in the Chinese population, successfully treated with laser photocoagulation therapy.
- For patients with OCA type 2, even with incomplete pigment deficiency, laser photocoagulation therapy can effectively treat ROP.
- Genetic analysis is crucial for guiding treatment choices in patients with such rare comorbidities.